Carcinogenesis Advance Access originally published online on June 9, 2008
Carcinogenesis 2008 29(8):1538-1545; doi:10.1093/carcin/bgn137
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Superoxide-mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr(VI)-induced apoptosis
1 Department of Pharmaceutical Sciences, West Virginia University, Morgantown, WV 26506, USA
2 Department of Pharmaceutical Sciences, Chiangmai University, Chiangmai 50200, Thailand
3 Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA
* To whom correspondence should be addressed. Tel: +304 293 1483; Fax: +304 293 2576; Email: nazad{at}hsc.wvu.edu
Hexavalent chromium [Cr(VI)] compounds are redox cycling environmental carcinogens that induce apoptosis as the primary mode of cell death. Defects in apoptosis regulatory mechanisms contribute to carcinogenesis induced by Cr(VI). Activation of apoptosis signaling pathways is tightly linked with the generation of reactive oxygen species (ROS). Likewise, ROS have been implicated in the regulation of Cr(VI)-induced apoptosis and carcinogenicity; however, its role in Cr(VI)-induced apoptosis and the underlying mechanism are largely unknown. We report that ROS, specifically superoxide anion (
), mediates Cr(VI)-induced apoptosis of human lung epithelial H460 cells. H460
0 cells that lack mitochondrial DNA demonstrated a significant decrease in ROS production and apoptotic response to Cr(VI), indicating the involvement of mitochondrial ROS in Cr(VI)-induced apoptosis. In agreement with this observation, we found that Cr(VI) induces apoptosis mainly through the mitochondrial death pathway via caspase-9 activation, which is negatively regulated by the antiapoptotic protein Bcl-2. Furthermore,
induced apoptosis in response to Cr(VI) exposure by downregulating and degrading Bcl-2 protein through the ubiquitin–proteasomal pathway. This study reveals a novel mechanism linking
with Bcl-2 stability and provides a new dimension to ROS-mediated Bcl-2 downregulation and apoptosis induction.
Abbreviations: AMC, amino-4-methylcoumarin; ROS, reactive oxygen species;
, superoxide anion; Cr(VI), hexavalent chromium; H2O2, hydrogen peroxide; SOD, superoxide dismutase; GPx, glutathione peroxidase; DHE, dihydroethidium; DCF, dichlorofluorescein; MnTBAP, Mn(III)tetrakis (4-benzoic acid) porphyrin; DPI, diphenylene iodonium; ROT, rotenone; LAC, lactacystin; LY83583, 6-anilinoquinoline-5,8-quinone
Received February 18, 2008; revised April 26, 2008; accepted May 26, 2008.